Echo45 Advisors LLC Abbott Laboratories Transaction History

Echo45 Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $3,176 - $3,507	-29 Reduced 1.46%	1,957 $222,000
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $179,117 - $219,254	1,986 New	1,986 $218,000
Q2 2023 Jul 31, 2023	SELL	$100.78 - $112.29 $22,272 - $24,816	-221 Reduced 10.15%	1,957 $213,000
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $14,044 - $16,531	-145 Reduced 6.24%	2,178 $220,000
Q4 2022 Jan 30, 2023	SELL	$95.06 - $111.52 $2,566 - $3,011	-27 Reduced 1.15%	2,323 $255,000
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $12,965 - $15,012	-134 Reduced 5.39%	2,350 $227,000
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $72,980 - $88,209	-715 Reduced 22.35%	2,484 $270,000
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $59,176 - $72,161	-519 Reduced 13.96%	3,199 $379,000
Q4 2021 Feb 28, 2022	BUY	$115.53 - $141.46 $429,540 - $525,948	3,718 New	3,718 $523,000

3,136

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Echo45 Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Echo45 Advisors LLC with notifications on news.